Graphite Bio, Inc. (GRPH) has a consensus analyst rating of Hold, based on 8 analysts covering the stock. Of those, 0 recommend buying, 7 recommend holding, and 1 recommend selling.
The analyst consensus price target for GRPH is $4.00, representing a +25.8% upside from the current price of $3.18. Price targets range from a low of $2.00 to a high of $7.00.
